Cetera Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,719
Closed -$189K 1619
2022
Q3
$189K Sell
10,719
-4,139
-28% -$85.3K 0.01% 1154
2022
Q2
$291K Buy
14,858
+54
+0.4% +$1.27K 0.01% 1059
2022
Q1
$435K Buy
14,804
+3,233
+28% +$96.4K 0.01% 953
2021
Q4
$451K Buy
11,571
+347
+3% +$13.8K 0.01% 934
2021
Q3
$433K Buy
11,224
+3,273
+41% +$133K 0.01% 933
2021
Q2
$332K Buy
7,951
+1,520
+24% +$57.6K 0.01% 1005
2021
Q1
$230K Buy
+6,431
New +$234K 0.01% 1083

Other funds holding BSTZ

Cetera Advisors's BSTZ Position: Q4 2022 in Review

Cetera Advisors sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q4 2022, closing a stake of 10,719 shares — an estimated $189K sold.

Cetera Advisors first reported a position in BSTZ in Q1 2021 and held it in 7 quarters. The position peaked at $451K in Q4 2021. 104 funds tracked by Wall St. Rank hold BSTZ as of Q4 2022.

  • Cetera Advisors reported no remaining BlackRock Science and Technology Term Trust position as of Q4 2022 after selling out during the quarter.
  • Cetera Advisors sold 10,719 BlackRock Science and Technology Term Trust shares in Q4 2022, an estimated $189K.
  • Cetera Advisors first reported a position in BlackRock Science and Technology Term Trust in Q1 2021 and held it in 7 quarters.
  • Cetera Advisors's BlackRock Science and Technology Term Trust position peaked at $451K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q4 2022.

Based on Cetera Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.